Spina E - Search Results

1

Effect of adjunctive duloxetine on the plasma concentrations of clozapine, olanzapine, and risperidone in patients with psychotic disorders.

Santoro V, D'Arrigo C, Spina E, Micò U, Muscatello MR, Zoccali R. Santoro V, et al. Among authors: spina e. J Clin Psychopharmacol. 2010 Oct;30(5):634-6. doi: 10.1097/JCP.0b013e3181ee2afe. J Clin Psychopharmacol. 2010. PMID: 20841963 No abstract available.

2

Olanzapine augmentation of paroxetine-refractory obsessive-compulsive disorder.

D'Amico G, Cedro C, Muscatello MR, Pandolfo G, Di Rosa AE, Zoccali R, La Torre D, D'Arrigo C, Spina E. D'Amico G, et al. Among authors: spina e. Prog Neuropsychopharmacol Biol Psychiatry. 2003 Jun;27(4):619-23. doi: 10.1016/S0278-5846(03)00050-2. Prog Neuropsychopharmacol Biol Psychiatry. 2003. PMID: 12787848 Clinical Trial.

3

Lack of a pharmacokinetic interaction between mirtazapine and the newer antipsychotics clozapine, risperidone and olanzapine in patients with chronic schizophrenia.

Zoccali R, Muscatello MR, Torre DL, Malara G, Canale A, Crucitti D, D'Arrigo C, Spina E. Zoccali R, et al. Among authors: spina e. Pharmacol Res. 2003 Oct;48(4):411-4. doi: 10.1016/s1043-6618(03)00178-6. Pharmacol Res. 2003. PMID: 12902213

4

Metabolic drug interactions with new psychotropic agents.

Spina E, Scordo MG, D'Arrigo C. Spina E, et al. Fundam Clin Pharmacol. 2003 Oct;17(5):517-38. doi: 10.1046/j.1472-8206.2003.00193.x. Fundam Clin Pharmacol. 2003. PMID: 14703714 Review.

5

The effect of mirtazapine augmentation of clozapine in the treatment of negative symptoms of schizophrenia: a double-blind, placebo-controlled study.

Zoccali R, Muscatello MR, Cedro C, Neri P, La Torre D, Spina E, Di Rosa AE, Meduri M. Zoccali R, et al. Among authors: spina e. Int Clin Psychopharmacol. 2004 Mar;19(2):71-6. doi: 10.1097/00004850-200403000-00003. Int Clin Psychopharmacol. 2004. PMID: 15076014 Clinical Trial.

6

Risperidone treatment of children with autistic disorder: effectiveness, tolerability, and pharmacokinetic implications.

Gagliano A, Germanò E, Pustorino G, Impallomeni C, D'Arrigo C, Calamoneri F, Spina E. Gagliano A, et al. Among authors: spina e. J Child Adolesc Psychopharmacol. 2004 Spring;14(1):39-47. doi: 10.1089/104454604773840472. J Child Adolesc Psychopharmacol. 2004. PMID: 15142390 Clinical Trial.

7

Plasma risperidone concentrations during combined treatment with sertraline.

Spina E, D'Arrigo C, Migliardi G, Morgante L, Zoccali R, Ancione M, Madia A. Spina E, et al. Ther Drug Monit. 2004 Aug;26(4):386-90. doi: 10.1097/00007691-200408000-00008. Ther Drug Monit. 2004. PMID: 15257068 Clinical Trial.

8

Plasma concentrations of risperidone and olanzapine during coadministration with oxcarbazepine.

Rosaria Muscatello M, Pacetti M, Cacciola M, La Torre D, Zoccali R, D'Arrigo C, Migliardi G, Spina E. Rosaria Muscatello M, et al. Among authors: spina e. Epilepsia. 2005 May;46(5):771-4. doi: 10.1111/j.1528-1167.2005.71104.x. Epilepsia. 2005. PMID: 15857446 Free article.

9

Effect of fluvoxamine on plasma risperidone concentrations in patients with schizophrenia.

D'Arrigo C, Migliardi G, Santoro V, Morgante L, Muscatello MR, Ancione M, Spina E. D'Arrigo C, et al. Among authors: spina e. Pharmacol Res. 2005 Dec;52(6):497-501. doi: 10.1016/j.phrs.2005.09.005. Epub 2005 Oct 11. Pharmacol Res. 2005. PMID: 16226034

10

Determination of olanzapine in human plasma by reversed-phase high-performance liquid chromatography with ultraviolet detection.

D'Arrigo C, Migliardi G, Santoro V, Spina E. D'Arrigo C, et al. Among authors: spina e. Ther Drug Monit. 2006 Jun;28(3):388-93. doi: 10.1097/01.ftd.0000211800.66569.c9. Ther Drug Monit. 2006. PMID: 16778724

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

412 results

Search Page

Filters